Bank of Montreal’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,970
| Closed | -$621K | – | 3789 |
|
|
2023
Q2 | $621K | Buy |
+22,970
| New | +$615K | ﹤0.01% | 2452 |
|
|
2021
Q4 | – | Sell |
-21,390
| Closed | -$886K | – | 3483 |
|
|
2021
Q3 | $886K | Buy |
21,390
+16,263
| +317% | +$670K | ﹤0.01% | 2567 |
|
|
2021
Q2 | $232K | Buy |
5,127
+1,060
| +26% | +$45.1K | ﹤0.01% | 3159 |
|
|
2021
Q1 | $165K | Sell |
4,067
-15
| -0.4% | -$569 | ﹤0.01% | 3194 |
|
|
2020
Q4 | $169K | Buy |
4,082
+2,490
| +156% | +$94.5K | ﹤0.01% | 3316 |
|
|
2020
Q3 | $57K | Buy |
1,592
+14
| +0.9% | +$506 | ﹤0.01% | 3369 |
|
|
2020
Q2 | $55K | Buy |
1,578
+1,195
| +312% | +$39.4K | ﹤0.01% | 3396 |
|
|
2020
Q1 | $12K | Sell |
383
-1,418
| -79% | -$57.4K | ﹤0.01% | 3414 |
|
|
2019
Q4 | $93K | Buy |
1,801
+429
| +31% | +$24.9K | ﹤0.01% | 3531 |
|
|
2019
Q3 | $75K | Sell |
1,372
-1
| -0.1% | -$51 | ﹤0.01% | 3434 |
|
|
2019
Q2 | $56K | Sell |
1,373
-43,827
| -97% | -$1.6M | ﹤0.01% | 3632 |
|
|
2019
Q1 | $1.37M | Buy |
45,200
+43,898
| +3,372% | +$1.5M | ﹤0.01% | 1885 |
|
|
2018
Q4 | $45K | Sell |
1,302
-116
| -8% | -$4.19K | ﹤0.01% | 3313 |
|
|
2018
Q3 | $59K | Sell |
1,418
-1,164
| -45% | -$46K | ﹤0.01% | 3316 |
|
|
2018
Q2 | $82K | Sell |
2,582
-38
| -1% | -$1.56K | ﹤0.01% | 3221 |
|
|
2018
Q1 | $130K | Sell |
2,620
-161
| -6% | -$9.1K | ﹤0.01% | 2848 |
|
|
2017
Q4 | $150K | Sell |
2,781
-16,369
| -85% | -$906K | ﹤0.01% | 2809 |
|
|
2017
Q3 | $1.11M | Sell |
19,150
-2,040
| -10% | -$107K | ﹤0.01% | 1924 |
|
|
2017
Q2 | $1.05M | Buy |
21,190
+2,341
| +12% | +$108K | ﹤0.01% | 1959 |
|
|
2017
Q1 | $818K | Sell |
18,849
-665
| -3% | -$31.7K | ﹤0.01% | 1931 |
|
|
2016
Q4 | $910K | Buy |
19,514
+18,864
| +2,902% | +$872K | ﹤0.01% | 1925 |
|
|
2016
Q3 | $31K | Sell |
650
-3,964
| -86% | -$196K | ﹤0.01% | 3191 |
|
|
2016
Q2 | $247K | Sell |
4,614
-1,127
| -20% | -$53.1K | ﹤0.01% | 2372 |
|
|
2016
Q1 | $257K | Buy |
5,741
+478
| +9% | +$19.4K | ﹤0.01% | 2325 |
|
|
2015
Q4 | $201K | Buy |
5,263
+1,440
| +38% | +$55.1K | ﹤0.01% | 2411 |
|
|
2015
Q3 | $122K | Buy |
3,823
+172
| +5% | +$6K | ﹤0.01% | 2514 |
|
|
2015
Q2 | $121K | Buy |
3,651
+1,137
| +45% | +$40.6K | ﹤0.01% | 2647 |
|
|
2015
Q1 | $104K | Sell |
2,514
-704
| -22% | -$28.5K | ﹤0.01% | 2614 |
|
|
2014
Q4 | $131K | Buy |
3,218
+91
| +3% | +$3.56K | ﹤0.01% | 2649 |
|
|
2014
Q3 | $114K | Sell |
3,127
-172
| -5% | -$7.43K | ﹤0.01% | 2762 |
|
|
2014
Q2 | $153K | Buy |
3,299
+482
| +17% | +$21.4K | ﹤0.01% | 2623 |
|
|
2014
Q1 | $116K | Sell |
2,817
-635
| -18% | -$23.6K | ﹤0.01% | 2731 |
|
|
2013
Q4 | $132K | Buy |
3,452
+1,424
| +70% | +$43.9K | ﹤0.01% | 2416 |
|
|
2013
Q3 | $48K | Buy |
+2,028
| New | +$45.5K | ﹤0.01% | 2841 |
|
Other funds holding ANIK
TI
CP
BFM
Bank of Montreal's ANIK Position: Q3 2023 in Review
Bank of Montreal sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 22,970 shares — an estimated $621K sold.
Bank of Montreal first reported a position in ANIK in Q3 2013 and held it in 34 quarters. The position peaked at $1.37M in Q1 2019. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.
- Bank of Montreal reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
- Bank of Montreal sold 22,970 Anika Therapeutics shares in Q3 2023, an estimated $621K.
- Bank of Montreal first reported a position in Anika Therapeutics in Q3 2013 and held it in 34 quarters.
- Bank of Montreal's Anika Therapeutics position peaked at $1.37M in Q1 2019.
- 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.
Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.